Photo of Lisa Murkowski
R United States Senate · Alaska

Sen. Lisa Murkowski

Compare
Total votes
1,037
all sessions
Attendance
98%
25 missed
Near the chamber average
With party
76%
of cast votes
Lower than 99% of chamber peers
Bipartisan score
12%
some cross-party votes
Higher than 95% of chamber peers
Sponsored
982
bills & resolutions
Near the chamber average
Committees
14
assignments
982 bills and resolutions

Sponsored bills

Total
982
Primary
147
Co-sponsor
835
This page
982
matching current filters
Primary S 325
Signed into law · Ohio Senate · Lead sponsor
A bill to amend the Alyce Spotted Bear and Walter Soboleff Commission on Native Children Act to extend the deadline for a report by the Alyce Spotted Bear and Walter Soboleff Commission on Native Children, and for other purposes.

This bill extends the deadline, from three years to five years, for the Alyce Spotted Bear and Walter Soboleff Commission on Native Children to submit its report to the President and Congress. The commission was established to conduct a comprehensive study of federal, state, local, and tribal programs that serve Native children and to develop plans for federal policy related to Native children.

Signed into law Sep 24, 2021 0 co-sponsors
Primary S 2818
In committee · Ohio Senate · Lead sponsor
Cruising for Alaska's Workforce Act

Cruising for Alaska's Workforce Act This bill authorizes foreign vessels that carry more than 1,000 passengers (e.g., cruise ships) to transport passengers between a port in Alaska and another U.S. port, either directly or by way of a foreign port. The authorization generally expires 270 days after a notification that a U.S. vessel offers the same transport.

In committee Sep 23, 2021 0 co-sponsors
Co-sponsor S 2777
In committee · Ohio Senate · Co-sponsor
Equitable Payments for Nursing Facilities Act of 2021

Equitable Payments for Nursing Facilities Act of 2021 This bill allows the Centers for Medicare & Medicaid Services to adjust the federal per diem payment rate for Medicare skilled nursing facilities in Alaska or Hawaii to reflect the unique circumstances of such facilities.

In committee Sep 21, 2021 1 co-sponsor
Co-sponsor S 2425
In committee · Ohio Senate · Co-sponsor
Suicide Prevention Lifeline Improvement Act of 2021

Suicide Prevention Lifeline Improvement Act of 2021 This bill reauthorizes through FY2027 and expands the requirements for the National Suicide Prevention Lifeline Program. Specifically, the Substance Abuse and Mental Health Services Administration (SAMHSA) must undertake efforts to raise awareness about the program and improve data collection and analysis of demographic information related to the program. In addition, SAMHSA must develop a plan to ensure the provision of high-quality service. The bill also directs the Government Accountability Office to study the program.

In committee Sep 21, 2021 1 co-sponsor
Co-sponsor S 2753
In committee · Ohio Senate · Co-sponsor
Protecting Children of Long-term Visa Holders Act of 2021

America's Children Act or the Protecting Children of Long-term Visa Holders Act of 2021 This bill provides lawful permanent resident status to certain college graduates who entered the United States as children and addresses other immigration-related issues. Specifically, this bill allows an alien to apply for lawful permanent resident status if the alien (1) was lawfully admitted into the United States as a dependent child of an alien on a temporary worker visa, (2) was in the United States with such status for at least four years, (3) has graduated from an institution of higher education in the United States, and (4) is not deportable or otherwise inadmissible. In addition, the alien must have been lawfully present in the United States for at least 10 years at the time of the application. The bill also modifies various provisions related to the calculation of an alien's age for immigration purposes and the priority date of certain immigration-related applications.

In committee Sep 15, 2021 1 co-sponsor
Co-sponsor S 2721
In committee · Ohio Senate · Co-sponsor
A bill to require the Internal Revenue Service to issue a report on the tax gap, to establish a fellowship program within the Internal Revenue Service to recruit mid-career tax professionals to create and participate in an audit task force, and for other purposes.

This bill requires the Internal Revenue Service (IRS) to report to Congress on projections of the estimated tax gap (i.e., the difference between tax liabilities owed to the IRS and those liabilities that the IRS actually collects). The IRS may use artificial intelligence and related data analysis tools to calculate a tax gap projection. The bill also requires the Joint Committee on Taxation to issue periodic reports to the congressional tax committees on the tax gap projection. The bill restricts IRS funding to FY2021 levels for audits and enforcement until it publishes an updated tax gap projection. Funding is also restricted for certain purposes, including (1) targeting U.S. citizens who exercise their First Amendment rights, (2) targeting a group for regulatory scrutiny based on its ideological beliefs, and (3) auditing individual taxpayers with an adjusted gross income of less than $400,000. The bill directs the IRS to establish a fellowship program to recruit private sector tax experts to join the IRS to create and participate in the audit task force. The purposes of the tax force include performing audit case selection, educating IRS employees on emerging issues, auditing selected taxpayers, addressing offshore tax evasion, and identifying, mentoring, and training IRS junior employees with respect to audits.

In committee Sep 13, 2021 1 co-sponsor
Co-sponsor S 2706
In committee · Ohio Senate · Co-sponsor
DIVERSE Trials Act

Diversifying Investigations Via Equitable Research Studies for Everyone Trials Act or the DIVERSE Trials Act This bill requires activities to increase diversity in clinical trials. It also expands reporting by laboratories that test for and diagnose COVID-19 and requires a study on data collection and data sharing during public health emergencies. Specifically, the Food and Drug Administration (FDA) must issue guidance on decentralized clinical trials to promote meaningful demographic and geographic diversity in patient engagement, enrollment, and participation. Decentralized clinical trials include those executed through telemedicine or other digital technologies to allow for the remote collection and assessment of clinical trial data. The FDA may also work with foreign regulators to harmonize international regulations governing decentralized clinical trials and the use of digital health technology. In addition, the Department of Health and Human Services (HHS) may support community education, outreach, and recruitment activities for clinical trials of treatments for conditions that disproportionately impact populations underrepresented in clinical trials. The bill also specifies that drug or device manufacturers may provide, subject to some limits, free digital health technologies and other remuneration to patients in approved clinical trials without violating laws that address fraud and abuse in federal programs. Furthermore, laboratories that test for and diagnose COVID-19 must report additional demographic data, including information about social determinants of health. HHS must also contract with the National Academy of Medicine to study and propose a design for an interoperable platform to facilitate data sharing during public health emergencies.

In committee Aug 10, 2021 1 co-sponsor
Showing 801 to 810 of 982 bills
Previous 1 80 81 82 99 Next